DRD2 rs11214606: Understanding This Genetic Variant
The rs11214606 variant is a single-nucleotide polymorphism located within the DRD2 gene, which encodes the dopamine D2 receptor. Research has investigated this variant for its potential associations with dopaminergic signaling and its role in the study of schizophrenia.
What each genotype means
Common DRD2 genotype
This is the most frequently observed genotype for this variant in many populations. Research into this specific variant has explored its potential role in dopaminergic signaling and schizophrenia risk, though current evidence remains limited and inconsistent. This genotype is generally considered the baseline for comparison in genetic studies.
This is the most common genotype, carried by the vast majority of individuals in most studied populations.
Heterozygous DRD2 variant
You carry one copy of the common allele and one copy of the less common T allele. Studies have investigated whether this variant influences dopamine receptor function or psychiatric risk, but findings are not definitive and evidence is considered limited. You should not interpret this as a diagnostic indicator for any condition.
This genotype is found in a small minority of the population, consistent with the reported minor allele frequency of approximately 0.022.
Homozygous minor DRD2 genotype
You carry two copies of the less common T allele. While this variant has been included in research regarding dopaminergic pathways and schizophrenia, the clinical significance of this specific genotype is not well-established. Please consult with a healthcare professional if you have concerns about your health or psychiatric history.
This is a rare genotype, occurring in a very small fraction of the population across most ancestral groups.
What is rs11214606?
The rs11214606 variant is a specific genetic change, or single-nucleotide polymorphism (SNP), found on chromosome 11. In the context of human genetics, a SNP represents a variation at a single position in the DNA sequence among individuals. This particular variant is situated within the DRD2 gene, a region of the genome that has been extensively studied due to its critical role in brain function. Scientists track these variants to understand how subtle differences in our genetic code might influence biological processes. While rs11214606 is cataloged in major databases like dbSNP, it is important to recognize that the presence of a variant does not inherently imply a health condition. Instead, it serves as a marker that researchers use to explore the complex relationship between genetics, brain chemistry, and various behavioral or clinical traits.
The Role of the DRD2 Gene
The DRD2 gene provides the instructions for creating the dopamine D2 receptor, a protein that plays a vital role in the central nervous system. Dopamine is a neurotransmitter, a chemical messenger that helps transmit signals between nerve cells. The D2 receptor is a G-protein coupled receptor that helps regulate these signals by inhibiting the activity of adenylyl cyclase, a process essential for modulating mood, motivation, attention, and motor control. Because dopamine signaling is fundamental to how the brain processes rewards and regulates movement, the DRD2 gene is considered a primary candidate in neurobiological research. Variations in this gene may influence how receptors are expressed or how effectively they respond to dopamine, which is why scientists focus on this gene when studying conditions that involve altered dopaminergic pathways, such as schizophrenia.
Research and Evidence Strength
The association between rs11214606 and health outcomes is currently classified as having limited evidence. While the DRD2 gene is widely recognized as a risk gene for schizophrenia in scientific literature, the specific contribution of individual variants like rs11214606 remains a subject of ongoing investigation. Some studies have explored this variant in the context of neurocognition and antipsychotic treatment response, looking for links between genetic markers and how the brain functions during specific tasks. However, it is crucial to note that schizophrenia is a highly polygenic condition, meaning it is influenced by the cumulative effect of many different genetic variants, as well as environmental factors. Because the evidence for this specific SNP is limited, it is not currently used as a diagnostic tool. Findings from small-scale studies often require replication in larger, more diverse populations to confirm their clinical significance.
What You Can Do With This Information
Genetic information regarding variants like rs11214606 is primarily intended for educational and research purposes. If you have received results from a genetic test, it is important to understand that this data does not constitute a medical diagnosis. Because the evidence linking this specific variant to health outcomes is limited and mixed, it cannot be used to predict individual health risks or determine treatment paths. If you are concerned about your mental health or have questions about how genetics might influence your response to medications, you should consult with a qualified healthcare provider or a genetic counselor. They can help interpret your results within the context of your overall health history. Never make changes to prescribed medications or health routines based on genetic reports without first discussing them with your clinician or pharmacist.
How common is this variant?
The minor allele frequency for rs11214606 is approximately 0.02204, indicating that it is a relatively uncommon variant across general populations.
Frequently asked questions
Is rs11214606 a diagnostic test for schizophrenia?
No, rs11214606 is not a diagnostic test. Schizophrenia is a complex, polygenic condition, and no single genetic variant can determine if an individual will develop the disorder.
What does it mean if I have the T allele?
Having the T allele simply means you carry a specific genetic variation at the rs11214606 site. It does not indicate a health condition or a specific medical risk.
Should I change my medication based on this result?
No. You should never change your medication or treatment plan based on genetic test results without consulting your doctor or pharmacist first.
Where can I find more information about DRD2?
You can find reliable information about the DRD2 gene and its functions through resources like MedlinePlus Genetics or the National Center for Biotechnology Information (NCBI) Gene database.
Sources & further reading
Educational information only, last refreshed 10/2/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs11214606?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in DRD2
This dopamine receptor D2 variant was investigated as a potential genetic risk factor for endometriosis-related infertility.
This SNP is located in a linkage disequilibrium block of the DRD2 gene and was evaluated for links to endometriosis-related infertility.
Commonly studied variant in the Dopamine D2 Receptor gene linked to cognitive flexibility and processing speed.
Also known as TaqIB, this dopamine receptor D2 intronic variant is associated with reward processing, cognitive flexibility, and sensory preference traits.
This SNP in the dopamine receptor D2 gene was investigated as a potential genetic risk factor for endometriosis-related infertility.
This variant in the dopamine receptor D2 gene has shown suggestive association with polysomnographically determined sleep latency.